Prostaglandin D2 receptor 2


  • Accession: Q9Z2J6
  • Swissprot: PD2R2_MOUSE
  • Organism: Mus musculus
  • Gene: Ptgdr2
  • Target class: Unclassified

Drug Relations:

A naturally occurring prostaglandin that has oxytocic, luteolytic, and abortifacient activities. Due to its vasocontractile properties, the compound has a variety of other biological actions. Bioactivity details MOA
The most common and most biologically active of the mammalian prostaglandins. It exhibits most biological activities characteristic of prostaglandins and has been used extensively as an oxytocic agent. The compound also displays a protective effect on the intestinal mucosa. Bioactivity details MOA
A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Additional data needed to determine whether in vitro activity against SARS-CoV-2 corresponds with clinical efficacy in the treatment of COVID-19. Bioactivity details MOA
thromboxane A2 receptor antagonist; BAY u 3405 & 3406 are enantiomers of each other Bioactivity details MOA